Business

Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS)

Featured article strengthens growing body of clinical evidence for Nociscan by highlighting a successful case studySpecial Pain issue features breakthrough innovations shaping the future of spine careIJSS publishes over 150 articles annually representing 40+ nations BROOMFIELD, Colo., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algor

articleAclarion, Inc.December 4, 20255/company/aclarion-inc/news/aclarion-announces-publication-nociscan-article-130000350
Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS)

About this update from Aclarion, Inc.

[{"type":"image","alt":"Aclarion, Inc.","displaySize":"","headline":null,"caption":"Aclarion, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":140,"height":83,"url":"https://media.zenfs.com/en/globenewswire.com/ba6de721dd8ef6e3bce232e051476ebf"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/JqjNbxSKpdl2ksI_nXtiLg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTEyNTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/ba6de721dd8ef6e3bce232e051476ebf","width":140,"height":83}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Featured article strengthens growing body of clinical evidence for Nociscan by highlighting a successful case study","length":115,"tagName":"p"}]},{"val":[{"type":"text","content":"Special Pain issue features breakthrough innovations shaping the future of spine care","length":85,"tagName":"p"}]},{"val":[{"type":"text","content":"IJSS publishes over 150 articles annually representing 40+ nations","length":66,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":266,"olType":false},{"type":"text","content":"BROOMFIELD, Colo., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today the publication of a featured article Tech Update, sponsored by Aclarion, in the upcoming Special Pain Issue of the International Journal of Spine Surgery (IJSS). ","length":499,"tagName":"p"},{"type":"text","content":"“The Special Pain Issue of IJSS highlights a simple truth: pain is not just a symptom—it is a complex neurobiological, psychological, and existential condition,” said Morgan P. Lorio, MD, FACS, Guest Editor. “As more granular diagnostics and increasingly granular ICD-10 classifications emerge—including pre-MRS tools capable of identifying the pain generator—clinicians are gaining new ways to ‘see’ pain that were previously inaccessible. This edition brings together innovations that integrate objective biomarkers with clinical judgment and ultimately improve how we diagnose, treat, and prevent suffering. IJSS is publishing this issue now because the field is at an inflection point, and our patients deserve nothing less than a more compl...

More updates from Aclarion, Inc.

IJSSAclarion, Incchronic low back painlumbar spineIssueInternational Journal of Spine SurgerypatientsphysiciansThe Company